Summary

Persistence Market Research has recently released a comprehensive report on the worldwide market for pain management therapeutics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global pain management therapeutics market from 2025 to 2032.

Key Insights: Pain Management Therapeutics Market

• Market Size (2025E): US$ 79.7 Bn
• Projected Market Value (2032F): US$ 103.0 Bn
• Global Market Growth Rate (CAGR 2025 to 2032):3.7%

Pain Management Therapeutics Market – Report Scope:

Pain management therapeutics play a critical role in alleviating acute and chronic pain associated with conditions such as arthritis, cancer, neuropathic disorders, postoperative recovery, and musculoskeletal injuries. These therapeutics include a wide range of pharmacological solutions such as non-opioid analgesics, opioids, adjuvant therapies, and emerging biologics, along with non-pharmacological interventions.

The pain management therapeutics market caters to hospitals, specialty clinics, pain management centers, and homecare settings. Market growth is driven by the rising prevalence of chronic pain conditions, an aging global population, increasing surgical procedures, and advancements in drug delivery technologies that enhance efficacy while reducing adverse effects.

Market Growth Drivers:

The global pain management therapeutics market is propelled by several key factors, including the increasing incidence of chronic diseases such as osteoarthritis, cancer, and diabetic neuropathy. Growing awareness regarding pain management solutions and improved access to healthcare services further support market expansion.

Technological advancements in formulation science, including extended-release drugs, transdermal patches, and targeted biologics, have improved patient outcomes and treatment compliance. Additionally, the rising demand for non-opioid and minimally addictive pain therapies, driven by concerns surrounding opioid misuse, is reshaping treatment protocols and accelerating innovation across the market.

Market Restraints:

Despite favorable growth prospects, the pain management therapeutics market faces challenges related to strict regulatory frameworks, concerns over opioid addiction, and adverse drug reactions. Regulatory scrutiny on opioid prescriptions has limited their use in several regions, impacting market growth.

Moreover, high development costs for novel pain therapeutics, coupled with lengthy clinical trials and approval processes, pose significant barriers for new entrants. Limited reimbursement for advanced pain management therapies in certain healthcare systems further restricts adoption, particularly in low- and middle-income economies.

Market Opportunities:

The pain management therapeutics market presents significant growth opportunities driven by the shift toward personalized medicine, biologic therapies, and non-opioid alternatives. The development of novel drug classes, such as nerve growth factor (NGF) inhibitors and cannabinoid-based therapeutics, opens new avenues for effective pain control.

Furthermore, the integration of digital health platforms, remote patient monitoring, and multimodal pain management approaches enhances treatment optimization and patient engagement. Strategic collaborations, increased R&D investments, and expansion into emerging markets are expected to create sustainable growth opportunities for industry participants.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the pain management therapeutics market globally?
• Which drug classes and therapies are witnessing higher adoption across different pain indications?
• How are regulatory changes and opioid stewardship programs influencing market dynamics?
• Who are the key players contributing to the pain management therapeutics market, and what strategies are they adopting to strengthen their market presence?
• What are the emerging trends and future prospects in the global pain management therapeutics market?

Competitive Intelligence and Business Strategy:

Leading players in the global pain management therapeutics market, including Pfizer Inc., Johnson & Johnson, and AbbVie Inc., focus on product innovation, portfolio diversification, and strategic acquisitions to maintain a competitive edge.

These companies invest heavily in R&D to develop safer and more effective pain therapies, particularly non-opioid and targeted treatments. Partnerships with research institutions, biotechnology firms, and healthcare providers facilitate clinical development and market penetration. Emphasis on patient-centric solutions and compliance with evolving regulatory standards remains central to long-term growth strategies.

Key Companies Profiled:

• Abbott Laboratories
• Teva Pharmaceutical
• Endo International plc
• Pfizer Inc.
• Mallinckrodt Pharmaceuticals plc
• Depomed, Inc.
• GSK plc
• Merck & Co.
• Novartis AG
• AstraZeneca plc

Market Segmentation

By Drug Class
• NSAIDs
• Opioids
• Anesthetics
• Antidepressants
• Anticonvulsants

By Indication
• Arthritic Pain
• Neuropathic Pain
• Chronic Back Pain
• Cancer Pain
• Post-operative Pain

By Distribution Channel
• Online Pharmacy
• Retail Pharmacy
• Hospital Pharmacy

By Region
• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Pain Management Therapeutics Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Key Trends
2.3. Macro-economic Factors
2.3.1. Impact of Inflation and Disposable Income on Access to Pain Management Therapies
2.3.2. Public and Private Investment Trends in Healthcare and Pain Management Therapeutics
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Drug Adoption Analysis
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. PESTLE Analysis
3.5. Porter’s Five Force Analysis
4. Pricing Analysis, 2024A
4.1. Key Highlights
4.2. Price Variation across Drug Classes and Indications
4.3. Cost Components by Drug Type and Delivery Mechanism
5. Global Pain Management Therapeutics Market Outlook
5.1. Key Highlights
5.1.1. Market Volume (Units) Projections
5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
5.3. Global Pain Management Therapeutics Market Outlook: Drug Class
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Drug Class, 2019-2024
5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025-2032
5.3.3.1. NSAIDs
5.3.3.2. Opioids
5.3.3.3. Anesthetics
5.3.3.4. Antidepressants
5.3.3.5. Anticonvulsants
5.3.3.6. Others
5.3.4. Market Attractiveness Analysis: Drug Class
5.4. Global Pain Management Therapeutics Market Outlook: Indication
5.4.1. Introduction / Key Findings
5.4.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2024
5.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
5.4.3.1. Arthritic Pain
5.4.3.2. Neuropathic Pain
5.4.3.3. Chronic Back Pain
5.4.3.4. Cancer Pain
5.4.3.5. Post-operative Pain
5.4.3.6. Others
5.4.4. Market Attractiveness Analysis: Indication
5.5. Global Pain Management Therapeutics Market Outlook: Distribution Channel
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2024
5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
5.5.3.1.
5.5.3.1.1. Online Pharmacy
5.5.3.1.2. Retail Pharmacy
5.5.3.1.3. Hospital Pharmacy
5.5.4. Market Attractiveness Analysis: Distribution Channel
6. Global Pain Management Therapeutics Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2024
6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia and Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Pain Management Therapeutics Market Outlook
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
7.2.1. By Country
7.2.2. By Drug Class
7.2.3. By Indication
7.2.4. By Distribution Channel
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
7.3.1. U.S.
7.3.2. Canada
7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025-2032
7.4.1. NSAIDs
7.4.2. Opioids
7.4.3. Anesthetics
7.4.4. Antidepressants
7.4.5. Anticonvulsants
7.4.6. Others
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
7.5.1.
7.5.1.1. Arthritic Pain
7.5.1.2. Neuropathic Pain
7.5.1.3. Chronic Back Pain
7.5.1.4. Cancer Pain
7.5.1.5. Post-operative Pain
7.5.1.6. Others
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
7.6.1. Online Pharmacy
7.6.2. Retail Pharmacy
7.6.3. Hospital Pharmacy
7.7. Market Attractiveness Analysis
8. Europe Pain Management Therapeutics Market Outlook
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
8.2.1. By Country
8.2.2. By Drug Class
8.2.3. By Indication
8.2.4. By Distribution Channel
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Turkey
8.3.8. Rest of Europe
8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025-2032
8.4.1. NSAIDs
8.4.2. Opioids
8.4.3. Anesthetics
8.4.4. Antidepressants
8.4.5. Anticonvulsants
8.4.6. Others
8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
8.5.1. Arthritic Pain
8.5.2. Neuropathic Pain
8.5.3. Chronic Back Pain
8.5.4. Cancer Pain
8.5.5. Post-operative Pain
8.5.6. Others
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
8.6.1. Online Pharmacy
8.6.2. Retail Pharmacy
8.6.3. Hospital Pharmacy
8.7. Market Attractiveness Analysis
9. East Asia Pain Management Therapeutics Market Outlook
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
9.2.1. By Country
9.2.2. By Drug Class
9.2.3. By Indication
9.2.4. By Distribution Channel
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
9.3.1. China
9.3.2. Japan
9.3.3. South Korea
9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025-2032
9.4.1. NSAIDs
9.4.2. Opioids
9.4.3. Anesthetics
9.4.4. Antidepressants
9.4.5. Anticonvulsants
9.4.6. Others
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
9.5.1. Arthritic Pain
9.5.2. Neuropathic Pain
9.5.3. Chronic Back Pain
9.5.4. Cancer Pain
9.5.5. Post-operative Pain
9.5.6. Others
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
9.6.1. Online Pharmacy
9.6.2. Retail Pharmacy
9.6.3. Hospital Pharmacy
9.7. Market Attractiveness Analysis
10. South Asia & Oceania Pain Management Therapeutics Market Outlook
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
10.2.1. By Country
10.2.2. By Drug Class
10.2.3. By Indication
10.2.4. By Distribution Channel
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
10.3.1. India
10.3.2. Southeast Asia
10.3.3. ANZ
10.3.4. Rest of South Asia & Oceania
10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025-2032
10.4.1. NSAIDs
10.4.2. Opioids
10.4.3. Anesthetics
10.4.4. Antidepressants
10.4.5. Anticonvulsants
10.4.6. Others
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
10.5.1. Arthritic Pain
10.5.2. Neuropathic Pain
10.5.3. Chronic Back Pain
10.5.4. Cancer Pain
10.5.5. Post-operative Pain
10.5.6. Others
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
10.6.1. Online Pharmacy
10.6.2. Retail Pharmacy
10.6.3. Hospital Pharmacy
10.7. Market Attractiveness Analysis
11. Latin America Pain Management Therapeutics Market Outlook
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
11.2.1. By Country
11.2.2. By Drug Class
11.2.3. By Indication
11.2.4. By Distribution Channel
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025-2032
11.4.1. NSAIDs
11.4.2. Opioids
11.4.3. Anesthetics
11.4.4. Antidepressants
11.4.5. Anticonvulsants
11.4.6. Others
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
11.5.1. Arthritic Pain
11.5.2. Neuropathic Pain
11.5.3. Chronic Back Pain
11.5.4. Cancer Pain
11.5.5. Post-operative Pain
11.5.6. Others
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
11.6.1. Online Pharmacy
11.6.2. Retail Pharmacy
11.6.3. Hospital Pharmacy
11.7. Market Attractiveness Analysis
12. Middle East & Africa Pain Management Therapeutics Market Outlook
12.1. Key Highlights
12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
12.2.1. By Country
12.2.2. By Drug Class
12.2.3. By Indication
12.2.4. By Distribution Channel
12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
12.3.1. GCC Countries
12.3.2. Egypt
12.3.3. South Africa
12.3.4. Northern Africa
12.3.5. Rest of Middle East & Africa
12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025-2032
12.4.1. NSAIDs
12.4.2. Opioids
12.4.3. Anesthetics
12.4.4. Antidepressants
12.4.5. Anticonvulsants
12.4.6. Others
12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
12.5.1. Arthritic Pain
12.5.2. Neuropathic Pain
12.5.3. Chronic Back Pain
12.5.4. Cancer Pain
12.5.5. Post-operative Pain
12.5.6. Others
12.6. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
12.6.1. Online Pharmacy
12.6.2. Retail Pharmacy
12.6.3. Hospital Pharmacy
12.7. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2024
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. Abbott Laboratories
13.3.1.1. Overview
13.3.1.2. Segments and Drug Classs
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. Teva Pharmaceutical
13.3.3. Endo International plc
13.3.4. Pfizer Inc.
13.3.5. Mallinckrodt Pharmaceuticals plc
13.3.6. Depomed, Inc.
13.3.7. GSK plc
13.3.8. Merck & Co.
13.3.9. Novartis AG
13.3.10. AstraZeneca plc
13.3.11. Others
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations